Federated Hermes’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-237
| Closed | -$481 | – | 2075 |
|
|
2025
Q1 | $481 | Sell |
237
-64
| -21% | -$130 | ﹤0.01% | 2024 |
|
|
2024
Q4 | $1.8K | Hold |
301
| – | – | ﹤0.01% | 1981 |
|
|
2024
Q3 | $2.94K | Sell |
301
-2,840
| -90% | -$27.7K | ﹤0.01% | 1911 |
|
|
2024
Q2 | $64.3K | Buy |
3,141
+147
| +5% | +$3.01K | ﹤0.01% | 1596 |
|
|
2024
Q1 | $135K | Buy |
+2,994
| New | +$135K | ﹤0.01% | 1547 |
|
|
2023
Q2 | – | Sell |
-3,858
| Closed | -$1.15M | – | 2112 |
|
|
2023
Q1 | $1.15M | Buy |
+3,858
| New | +$1.15M | ﹤0.01% | 1126 |
|
|
2020
Q4 | – | Sell |
-792
| Closed | -$549K | – | 2245 |
|
|
2020
Q3 | $549K | Sell |
792
-3,446
| -81% | -$2.39M | ﹤0.01% | 1453 |
|
|
2020
Q2 | $3.6M | Sell |
4,238
-1,260
| -23% | -$1.07M | 0.01% | 801 |
|
|
2020
Q1 | $1.97M | Buy |
+5,498
| New | +$1.97M | 0.01% | 901 |
|